Protective and ameliorative effects of the extracts of Cistanche tubulosa on locomotive syndrome.

Protective and ameliorative effects of the extracts of Cistanche tubulosa on locomotive syndrome. - Protective and ameliorative effects of the extracts of Cistanche tubulosa on locomotive syndrome.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036275

Enrollment

Registered

2019-04-01

Start date

2019-05-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subjects having the risk of locomotive syndrome

Interventions

Tretament test drug: Intake of powder containing the extracts of Cistanche tubulosa (1800 mg/bag), one bag per day, for 12 weeks. Treatment placebo:Intake of powder without the extract, one bag per d

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects who checked at least one item among "Loco check" between age 40 to 80 years old, who volunteers to attend this clinical study.

Exclusion criteria

Exclusion criteria: Subjects under 20 years old, pregnant or lactating. Subjects during medication such as muscle relaxants, osteoporosis drugs, rheumatoid arthritis drugs. Subjects having mental illnesses. Subjects judged being inappropriate by other reasons.

Design outcomes

Primary

Measure	Time frame
Function of locomotive systems	—

Countries

Japan

Contacts

Public ContactChihiro Tohda

University of Toyama Division of Neuromedical Science, Institute of Natural Medicine

chihiro@inm.u-toyama.ac.jp076-434-7646

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026